Exparel 1.3% 20ML 10S
Ended Awarded
- Contract number
- SPE2DX25FPHBU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $10,043
Award facts
- Contract value 100% obligated
- $10,042.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a firm fixed-price delivery order valued at $10,042.52 by the Defense Logistics Agency's Medical Supply Chain on August 19, 2025. The delivery order calls for the supply of EXPAREL 1.3% in 20 milliliter vials, with a quantity of 10 units. The award carries an ultimate completion date of September 16, 2025, and no set-aside designation was utilized in this procurement action. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a $499.99 billion vehicle valid through November 2026 that enables the agency to procure a comprehensive range of pharmaceutical products supporting military health facilities worldwide.
As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group specializes in distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to Department of Defense healthcare sites. EXPAREL, a liposomal bupivacaine formulation used for local anesthesia and post-operative pain management, represents the type of specialty pharmaceutical product the contractor routinely delivers through its established federal contract portfolio. The company's consistent performance as a woman-owned small business contractor demonstrates its competitive positioning in federal procurement markets without reliance on set-aside programs.
Quick answers
Who was awarded contract SPE2DX25FPHBU?
SPE2DX25FPHBU was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 19, 2025.
How much is contract SPE2DX25FPHBU worth?
The government has obligated $10,043 on SPE2DX25FPHBU.
Is contract SPE2DX25FPHBU an order under another contract?
Yes. SPE2DX25FPHBU is a delivery order under SPE2DX15D9762, an indefinite delivery contract.
Was contract SPE2DX25FPHBU competed?
The extent of competition for SPE2DX25FPHBU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award